XML 11 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating expenses    
Research and development $ 7,410 $ 8,113
General and administrative 3,459 2,997
Total operating expenses 10,869 11,110
Loss from operations (10,869) (11,110)
Other income, net 574 338
Net loss and comprehensive loss $ (10,295) $ (10,772)
Net loss per share, Basic $ (0.34) $ (0.75)
Net loss per share, Diluted $ (0.34) $ (0.75)
Weighted-average common shares outstanding, Basic 29,989,400 14,285,905
Weighted Average Number of Shares Outstanding, Diluted 29,989,400 14,285,905